|
Market Closed -
Nasdaq
01:30:00 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 385.65 USD | +1.55% |
|
+2.20% | +17.82% |
| 16/09 | Sling Therapeutics raises $123 million to advance thyroid eye disease drug | RE |
| 15/09 | Amgen Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 11:30 AM |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 21TCr | |||||
| 1,02700Cr | |||||
| 65TCr | - | ||||
| 47TCr | |||||
| 35TCr | |||||
| 27TCr |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
